NCT02752607View on ClinicalTrials.gov

Reduction to Preventive Doses of Enoxaparin After 3 to 6 Months of Treatment With Blood Thinners for Cancer-associated Blood Clots

TerminatedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

November 9, 2018

Study Completion Date

November 9, 2018

Conditions
Deep Vein Thrombosis
Trial Locations (7)

B3H 1V7

Queen Elizabeth II Medical Centre, Halifax

K1H 8L6

The Ottawa Hospital Research Institute, Ottawa

J4V 2H1

Hôpital Charles-Le Moyne, Greenfield Park

H3T 1E2

The Jewish General Hospital, Montreal

H3T 1M5

St-Mary's Hospital, Montreal

H4A 3J1

The McGill University Health Centre - Glen Site, Montreal

H4J 1C5

Hôpital Sacré-Coeur, Montreal

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Dr. Vicky Tagalakis

OTHER